Insulin Delivery Devices
Authors: PHILIP FELIG
Journal: Annals of Internal Medicine (1980)

Editorial1 October 1980Insulin Delivery DevicesPHILIP FELIG, M.D., WILLIAM V. TAMBORLANE, M.D.PHILIP FELIG, M.D.Search for more papers by this author, WILLIAM V. TAMBORLANE, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-93-4-627 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptManagement of the insulin-dependent diabetic has long been characterized by debate between those advocating "tight" and those advocating "loose" control of blood glucose levels (1). Efforts to resolve this debate on the basis of retrospective or prospective evaluations of the effect of blood glucose control on the development of the long-term vascular and neurologic complications of diabetes have been inconclusive (2, 3). In recent years the focus has shifted from attempting to determine how diligent the patient, the physician, or both should be in applying conventional treatment to the development of newer forms of treatment such as islet cell transplantation...References1. INGELFINGER F. Debates on diabetes. N Engl J Med. 1977;296:1228-30. Editorial. CrossrefMedlineGoogle Scholar2. BONDYFELIG PP. Relationship of diabetic control to development of vascular complications. Med Clin North Am. 1971;55:889-97. CrossrefGoogle Scholar3. ASHIKAGABORODICSIMS TGE. Multiple daily insulin injections in the treatment of diabetic retinopathy: the Job study revisited. Diabetes. 1978;27:592-6. CrossrefMedlineGoogle Scholar4. MOLNARTAYLORLANGWORTHY GWA. Plasma immunoreactive insulin patterns in insulin-treated diabetics: studies during continuous blood glucose monitoring. Mayo Clin Proc. 1972;47:709-19. MedlineGoogle Scholar5. SERVICEMOLNARROSEVEARACKERMANGATEWOODTAYLOR FGJELW. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes. 1970;19:644-55. CrossrefMedlineGoogle Scholar6. RASKIN P. Diabetic regulation and its relationship to microangiopathy. Metabolism. 1978;27:235-52. CrossrefMedlineGoogle Scholar7. MAURERSUTHERLANDSTAFFES SDM. Pancreatic islet transplantation: effects on the glomerular lesions of experimental diabetes in the rat. Diabetes. 1974;23:748-53. CrossrefMedlineGoogle Scholar8. GOETZ F. Early experiments in human pancreas transplantation. Diabetes. 1980;29 (Suppl 1):1-2. CrossrefMedlineGoogle Scholar9. SANTIAGOCLEMENSCLARKEKIPNIS JAWD. Closed-loop and open-loop devices for blood glucose control in normal and diabetic subjects. Diabetes. 1979;28:71-81. CrossrefMedlineGoogle Scholar10. ALBISSERLEIBELEWART ABT. Clinical control of diabetes by the artificial pancreas. Diabetes. 1974;23:397-404. CrossrefMedlineGoogle Scholar11. SLAMAHAUTECOUVERTUREASSANTCHOBROUTSKY GMRG. One to five days of continuous intravenous insulin infusion on seven diabetic patients. Diabetes. 1974;23:732-8. CrossrefMedlineGoogle Scholar12. GENUTHMARTIN SP. Control of hyperglycemia in adult diabetics by pulsed insulin delivery. Diabetes. 1977;26:571-81. CrossrefMedlineGoogle Scholar13. DECKERTLORUP TB. Regulation of brittle diabetics by a pre-planned insulin infusion programme. Diabetologia. 1976;12:573-9. CrossrefMedlineGoogle Scholar14. PICKUPKEENPARSONS JHJ. Continuous subcutaneous insulin infusion: an approach to achieving normoglycemia. Br Med J. 1978;1:204-7. CrossrefMedlineGoogle Scholar15. TAMBORLANESHERWINGENELFELIG WRMP. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med. 1979;300:573-8. CrossrefMedlineGoogle Scholar16. PICKUPKEENPARSONSALBERTIROWE JHJKA. Continuous subcutaneous insulin infusion: improved blood-glucose and intermediary-metabolite control in diabetics. Lancet. 1979;1:1255. CrossrefMedlineGoogle Scholar17. TAMBORLANESHERWINGENELFELIG WRMP. Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system. Am J Med. 1980;68:190-6. CrossrefMedlineGoogle Scholar18. CHAMPIONSHEPHARDRODGERDUPRE MGNJ. Continuous subcutaneous infusion of insulin in the management of diabetes mellitus. Diabetes. 1980;29:206-12. CrossrefMedlineGoogle Scholar19. TAMBORLANESHERWINGENEL WRM. Restoration of normal lipid and amino acid metabolism in diabetic patients treated with a portable insulin infusion pump. Lancet. 1979;1:1258-61. CrossrefMedlineGoogle Scholar20. TAMBORLANEKOIVISTOHENDLERGENELFELIG WVRMP. Normalization of the growth hormone and catecholamine response to exercise in juvenile-onset diabetic subjects treated with a portable insulin infusion pump. Diabetes. 1979;28:785-8. CrossrefMedlineGoogle Scholar21. RASKINPIETRIUNGER PAR. Changes in glucagon levels after four to five weeks of glucoregulation by portable insulin infusion pumps. Diabetes. 1979;28:1033-5. CrossrefMedlineGoogle Scholar22. SACCAHENDLERSHERWIN LRR. Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones. J Clin Endocrinol Metab. 1978;47:1160-1163. CrossrefMedlineGoogle Scholar23. WAHRENFELIGCERASILUFT JPER. Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus. J Clin Invest. 1972;51:1870-8. CrossrefMedlineGoogle Scholar24. NELSONMARLISSZINMAN JEB. Subcutaneous open loop insulin delivery: is a pump required? Diabetes. 1980;29 (Suppl 2):7A. Abstract. Google Scholar25. SHERWIN R. Role of the liver in glucose homeostasis. Diabetes Care. 1980;3:261-76. CrossrefMedlineGoogle Scholar26. BLACKARDNELSON WN. Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion. Diabetes. 1970;19:302-6. CrossrefMedlineGoogle Scholar27. HANNAZINMANNAKHOODA ABA. Insulin, glucagon, and amino acids during glycemic control by the artificial pancreas in diabetic man. Metabolism. 1980;29:321-32. CrossrefMedlineGoogle Scholar28. SACCÀSHERWINHENDLERFELIG LRRP. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. J Clin Invest. 1979;63:849-57. CrossrefMedlineGoogle Scholar29. KITABCHIFISHERBURGHEN AJG. Evaluation of a portable insulin infusion pump for outpatient management of brittle diabetes. Diabetes Care. 1979;2:421-4. CrossrefMedlineGoogle Scholar30. FELIGTAMBORLANESHERWINGENEL PWRM. Insulin-infusion pump for diabetes. N Engl J Med. 1979;301:1004-5. Letter CrossrefMedlineGoogle Scholar31. VIBERTIPICKUPJARRETTKEEN GJRH. Effect of control of blood glucose on urinary excretion of albumin and β2 microglobulin in insulin-dependent diabetics. N Engl J Med. 1979;300:638-41. CrossrefMedlineGoogle Scholar32. TAMBORLANESHERWINBERGMANEBERSOLEPUKLINFELIG WRMJJP. Can treatment of diabetes with a portable insulin pump reverse diabetic complications? Diabetes. 1980;29 (Suppl 2):18A. Abstract. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Yale University School of Medicine New Haven, Connecticut PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byMetabolic and Endocrine ChangesPotentiation of 14C-glucose oxidation by priming glucose loads: Effect of starvationNewer approaches to the control of the insulin-dependent diabetic patientIntensive Ambulatory Treatment of Insulin-Dependent DiabetesPHILIP FELIG, M. D., MICHAEL BERGMAN, M.D.Insulin pump treatment for diabetes: unanswered questionsInsulin, glucagon and oral hypoglycemic drugsToward an understanding of reproductive function in anorexia nervosaDiabetic Glomerulopathy May be Preventable 1 October 1980Volume 93, Issue 4Page: 627-629KeywordsBloodCell transplantationGlucoseInsulin ePublished: 1 December 2008 Issue Published: 1 October 1980 PDF downloadLoading ...